• Explore /
  • Poster
  • / Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01.

Combining low-dose regorafenib with pembrolizumab for patients with MSI-H colorectal cancer: REGPEM-CRC-01.

Abstract Poster

Authors

null

Ibrahim Halil Sahin

University of Pittsburgh Medical Center, Pittsburgh, PA

Ibrahim Halil Sahin , Sakti Chakrabarti , Ronan Wenhan Hsieh , Tullia C. Bruno , Jennifer Eva Selfridge , Vikram Gorantla , Roby Antony Thomas , John C. Rhee , Curtis Tatsuoka , David L. Bajor , Amit Mahipal , E. Gabriela Chiorean , Mohamedtaki Abdulaziz Tejani , Anwaar Saeed

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session C: Cancers of the Colon, Rectum, and Anus

Track

Colorectal Cancer,Anal Cancer

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT06006923

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr TPS238)

DOI

10.1200/JCO.2024.42.3_suppl.TPS238

Abstract #

TPS238

Poster Bd #

P6

Abstract Disclosures

Similar Posters

First Author: Celine Yeh

First Author: Luis A. Diaz Jr.

First Author: Tamara Snow

First Author: Susanna Varkey Ulahannan